Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
about
Role of Bmi-1 in regulation of ionizing irradiation-induced epithelial-mesenchymal transition and migration of breast cancer cellsThe PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinomaTWIST1 and BMI1 in Cancer Metastasis and ChemoresistanceCancer stem cells (CSCs), cervical CSCs and targeted therapiesA Novel Aspect of Tumorigenesis-BMI1 Functions in Regulating DNA Damage ResponseTumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugsPolycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic ImplicationsThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsB-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancerNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNANOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer-Initiating Cells.NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1.MUC1-C activates BMI1 in human cancer cells.USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 proteinDownregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.Alterations in RD(INK4/ARF) -mediated en bloc regulation of the INK4-ARF locus in human squamous cell carcinoma of the head and neck.Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapySimulating cancer growth with multiscale agent-based modelingBmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cellsPLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signalingMicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescenceInteraction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancerNUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.Bmi-1 expression modulates non-small cell lung cancer progression.miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors.MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression.Testing for Ancient Selection Using Cross-population Allele Frequency Differentiation.Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.
P2860
Q21089647-6CCA961F-DA59-407A-A4D6-A7D5974AE973Q24337113-2D8E8FF0-E21C-40CE-9562-2FCD773291C4Q26744196-E93EA23D-5C22-48FD-BBD1-3C2CD55B71AEQ26747144-6DB1DA98-A1B9-40EE-ACAD-67B05C4D42DCQ26774980-DE0134AB-068B-48B7-90B1-3394D9EF273CQ26777335-20F0730A-DD83-4225-94EE-12739CCFE31CQ26801380-A8257C91-A5E4-467A-846D-F08C464C6B1DQ27340125-4AE802F9-25F4-4CDB-817E-B2DEA46157E7Q28075362-57EBE15C-4D53-4335-AEE4-533922F064D9Q29620083-BBBB73E8-6443-4687-907C-69B589CA6150Q30764907-95BE3C85-1922-41F9-B944-DCD6D8A66310Q33601322-472A1100-1ABB-4797-A78A-FE96E101B63DQ33688773-AA1FD271-6C87-48EC-B4EE-9D4D8379A12DQ33704573-99B0F6B5-2778-4CA5-A7D3-6587523C613BQ33779463-DC8844FB-D39E-4F22-97C4-81E71F84F2EEQ33888935-8D9053CB-A824-4DB9-941B-1AE3D19A661CQ33916962-6582AD4B-4AD7-45E3-8EC3-0990E44F51EBQ34280071-43519321-1D06-4230-A110-E4A92176015DQ34436695-18354251-3787-4B74-B834-2637001DA12FQ34438611-D29CC53D-3CFE-4413-A027-BDC28FFAD411Q34469657-759A5112-852C-40F2-B6C5-89E7EABEF9A6Q34544617-1F2C6716-5AEE-41D0-B9E3-3C79011A19ADQ34720367-1C08E837-704E-461A-A3F5-2A0B26E4EC38Q34988940-91361635-DAEF-4861-8E73-55C9E66084E0Q35048897-BC4B9E8E-ECE1-4DE3-87C3-21B7036F20BAQ35069199-2A270536-F926-4C7C-B03D-4C744779305DQ35212784-862FDFF7-7B29-404A-AF3F-42FD5FC74511Q35451400-89AE9E1A-2F7F-4519-A23D-9246ADE33589Q35550186-FB74832F-A285-4BE2-8FFD-7B7518EC1EE2Q35674112-28AC50F9-B80D-4C43-A559-C9EE88D27C88Q35686653-82438A12-2DFD-4DED-9427-A0EB91AD87DCQ35826455-BD3157A0-A819-4C0B-98B2-F0A2BAC89199Q36200467-B0BF0152-1638-4600-AE04-69C53AC8E5D5Q36213077-400A370F-2331-474C-8ADA-6738D2983096Q36246408-E4BB06D6-84F2-4851-8A41-BCFDB5178DE9Q36621766-1CDA0051-F2A7-48FD-BA6E-FD7EE4614DC1Q36633508-C0F3CD27-2BDC-4CBE-87A9-7058C4F9665CQ36677342-13F0692B-14CB-4E7E-B5A2-2AA8C7E212E5Q36738799-CB53534F-A2CF-47A6-82F4-39FD95BEDC61Q36824956-6BB572C8-3901-4CB1-B9E1-9F808424EEB0
P2860
Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@ast
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@en
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@nl
type
label
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@ast
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@en
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@nl
prefLabel
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@ast
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@en
Role of BMI1, a stem cell fact ...... inical and clinical evidences.
@nl
P356
P1433
P1476
Role of BMI1, a stem cell fact ...... linical and clinical evidences
@en
P2093
Hifzur Rahman Siddique
Mohammad Saleem
P304
P356
10.1002/STEM.1035
P577
2012-03-01T00:00:00Z